U.S. Department of Health and Human Services
Clinical Trials Search Results
Search results 1 - 10 of 20 for Trials by Study Type, Expanded Access
Fostemsavir Compassionate Use Named Patient Program for the Treatment of Human Immunodeficiency Virus 1 (HIV-1)
Condition: HIV Infections
NCT ID: NCT04233047- Green tick iconAvailable
- Email this trial
Compassionate Use of Ibalizumab for the Treatment of HIV Infection
Condition: Human Immunodeficiency Virus (HIV)
NCT ID: NCT02028819- Red stop iconNo longer available
- Email this trial
TMC114-C226: An Early Access Program to Evaluate the Long-term Safety and Tolerability of TMC114 Combined With a Low Dose of Ritonavir (TMC114/r) With Other Antiretrovirals, for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens.
Condition: HIV Infections
NCT ID: NCT00245739- Red stop iconApproved for marketing
- Email this trial
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Condition: HIV Infections
NCT ID: NCT00062660- Red stop iconApproved for marketing
- Email this trial
GSK1265744 (Cabotegravir, CAB) for Named Patient/Compassionate Use in HIV
Condition: Infection, Human Immunodeficiency Virus
NCT ID: NCT03462810- Green tick iconAvailable
- Email this trial
Atazanavir for HIV Infected Individuals: An Early Access Program
Condition: HIV Infections
NCT ID: NCT00046345- Red stop iconNo longer available
- Email this trial
Early Access of MK0518 in Combination With an Optimized Background Antiretroviral Therapy (0518-023)
Condition: HIV Infections
NCT ID: NCT00377065- Red stop iconApproved for marketing
- Email this trial
An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection
Condition: HIV Infection
NCT ID: NCT00162227- Red stop iconNo longer available
- Email this trial
An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection: Canada
Condition: HIV Infection
NCT ID: NCT00162188- Red stop iconNo longer available
- Email this trial
Pre-Approval Access to Rilpivirine Long Acting (RPV LA) Injectable Suspension for the Treatment of a Participant With Human Immunodeficiency Virus (HIV)-1 Infection
Condition: HIV
NCT ID: NCT03847376- Green tick iconAvailable
- Email this trial
Email Updates
